机构:
AstraZeneca R&D Charnwood, Charnwood, EnglandAstraZeneca R&D Charnwood, Charnwood, England
Higenbottam, T
[1
]
Demoncheaux, E
论文数: 0引用数: 0
h-index: 0
机构:
AstraZeneca R&D Charnwood, Charnwood, EnglandAstraZeneca R&D Charnwood, Charnwood, England
Demoncheaux, E
[1
]
机构:
[1] AstraZeneca R&D Charnwood, Charnwood, England
来源:
DISEASE MARKERS IN EXHALED BREATH: BASIC MECHANISMS AND CLINICAL APPLICATIONS
|
2002年
/
346卷
关键词:
D O I:
暂无
中图分类号:
R-3 [医学研究方法];
R3 [基础医学];
学科分类号:
1001 ;
摘要:
The origin of an exhaled gas is a classical physiological question. The biology and chemistry of nitric oxide (NO) is complex. In physiological conditions, NO acts while dissolved in aqueous biological solutions [1]. At high picomolar concentrations, it causes relaxation of vascular smooth muscle [2]. This is a result of activation of intra-cellular soluble guanylyl cyclase that increases the concentration of cyclic guanosine monophosphate (cGMP) which in turn initiates relaxation [1]. The evidence that NO normally regulates pulmonary vascular resistance depends on two observations. Firstly, changes in resistance are seen with inhibition of the endothelial enzyme nitric oxide synthase (eNOS). Secondly, pulmonary vascular disease is associated with changes in NO production.
机构:
Manchester Univ NHS Fdn Trust, NIHR Manchester Clin Res Facil, Manchester, Lancs, EnglandManchester Univ NHS Fdn Trust, NIHR Manchester Clin Res Facil, Manchester, Lancs, England
Bikov, Andras
Meszaros, Martina
论文数: 0引用数: 0
h-index: 0
机构:
Semmelweis Univ, Dept Pulmonol, Budapest, HungaryManchester Univ NHS Fdn Trust, NIHR Manchester Clin Res Facil, Manchester, Lancs, England
Meszaros, Martina
Lazar, Zsofia
论文数: 0引用数: 0
h-index: 0
机构:
Semmelweis Univ, Dept Pulmonol, Budapest, HungaryManchester Univ NHS Fdn Trust, NIHR Manchester Clin Res Facil, Manchester, Lancs, England